Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Share buy-back week 34/2016


Posted on: 26 Aug 16

Announcement             

26 August 2016

 

Coloplast – transactions in connection with share buy-back programme

 

As mentioned in Announcement No. 4/2016 Coloplast has initiated the first part of the share buy-back programme totalling up to DKK 1bn. The first part of the programme of DKK500m is expected to take place from 29 February, 2016 to 29 August, 2016.

 

The following transactions have been executed during the period 22 August – 25 August 2016:

 

Date Number of shares Buying price Amount DKK
22 August 2016 1,000 506.00 506,000.00
23 August 2016 1,000 505.00 505,000.00
24 August 2016 5,000 503.50 2,517,500.00
25 August 2016 8,403 502.00 4,218,306.00
Accumulated until now under the programme 1,014,153
 
493.02
 
499,999,950.00
 

 

Henceforth, Coloplast owns 4,450,854 treasury B shares of DKK 1 equal to 2.06% of the company’s total share capital.

 

The first part of Coloplast’s share buy-back programme initiated 29 February 2016 (see announcement No. 4/2016) is hereby finalized.

 

Kind regards,

Investor Relations

Coloplast A/S

Tel. +45 4911 1800

   

For further information, please contact

 

Investors and analysts                                           

 

Ellen Bjurgert

Head of Investor Relations

Tel. +45 4911 1800/+45 4911 3376

Email: dkebj@coloplast.com

                                                                                          

Press and the media                                               

 

Maria Lindeberg

Sr. Media Relations Manager

Tel. 4911 3095

Email: dkmalg@coloplast.com

 

This announcement is available in a Danish and an English language version. In the event of discrepancies, the Danish version shall prevail.

 

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.

 

Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ more than 10,000 people.

 

The Coloplast logo is a registered trademark of Coloplast A/S. © 2016-08 All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark. 

GlobeNewswire
globenewswire.com

Last updated on: 27/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.